Simplex Trading’s Cumberland Pharmaceuticals CPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$172K Buy
26,600
+19,500
+275% +$93.5K ﹤0.01% 4896
2026
Q1
$23.1K Buy
+7,100
New +$27.4K ﹤0.01% 6654
2025
Q4
Sell
-7,100
Closed -$22K 8765
2025
Q3
$22K Buy
7,100
+4,500
+173% +$15K ﹤0.01% 7241
2025
Q2
$8K Sell
2,600
-2,000
-43% -$9.47K ﹤0.01% 7451
2025
Q1
$19K Sell
4,600
-7,700
-63% -$31.9K ﹤0.01% 6607
2024
Q4
$29K Buy
+12,300
New +$18.1K ﹤0.01% 6379
2023
Q3
Sell
-3,600
Closed -$5K 8799
2023
Q2
$5K Sell
3,600
-8,500
-70% -$14.7K ﹤0.01% 7891
2023
Q1
$23K Buy
+12,100
New +$28.8K ﹤0.01% 6767
2022
Q3
Sell
-700
Closed -$1K 10020
2022
Q2
$1K Buy
700
+100
+17% +$231 ﹤0.01% 9537
2022
Q1
$1K Buy
600
+100
+20% +$333 ﹤0.01% 10039
2021
Q4
$2K Buy
+500
New +$1.71K ﹤0.01% 9964
2015
Q2
Sell
-9
Closed -$1K 5259
2015
Q1
$1K Buy
+9
New +$56 ﹤0.01% 4426

Other funds holding CPIX

Simplex Trading's CPIX Position: Q2 2026 in Review

Simplex Trading opened a new position in Cumberland Pharmaceuticals (CPIX) in Q2 2026: 4,544 shares worth $29.4K. The stake represents ﹤0.01% of the portfolio and ranks #6769 among its holdings. This is a return to the name: Simplex Trading previously reported a position in CPIX as recently as Q2 2025.

Simplex Trading first reported a position in CPIX in Q4 2022 and has held it in 5 quarters since. The position peaked at $80K in Q1 2025. 32 funds tracked by Wall St. Rank hold CPIX as of Q2 2026.

  • Simplex Trading held 4,544 shares of Cumberland Pharmaceuticals worth $29.4K as of Q2 2026.
  • Cumberland Pharmaceuticals was a new Simplex Trading position in Q2 2026.
  • Cumberland Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #6769 holding.
  • Simplex Trading first reported a position in Cumberland Pharmaceuticals in Q4 2022 and has held it in 5 quarters since.
  • Simplex Trading's Cumberland Pharmaceuticals position peaked at $80K in Q1 2025.
  • 32 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.